LEADER 02621nam 2200745 a 450 001 9910456841803321 005 20200520144314.0 010 $a1-299-19138-X 010 $a0-8165-0126-2 035 $a(CKB)2550000000041450 035 $a(OCoLC)747413923 035 $a(CaPaEBR)ebrary10485540 035 $a(SSID)ssj0000538568 035 $a(PQKBManifestationID)11369646 035 $a(PQKBTitleCode)TC0000538568 035 $a(PQKBWorkID)10559723 035 $a(PQKB)10006592 035 $a(MiAaPQ)EBC3411729 035 $a(MdBmJHUP)muse12484 035 $a(Au-PeEL)EBL3411729 035 $a(CaPaEBR)ebr10485540 035 $a(CaONFJC)MIL450388 035 $a(OCoLC)923438005 035 $a(EXLCZ)992550000000041450 100 $a20101104d2011 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 14$aThe life-giving stone$b[electronic resource] $eethnoarchaeology of Maya metates /$fMichael T. Searcy 210 $aTucson $cUniversity of Arizona Press$dc2011 215 $a1 online resource (183 p.) 300 $aBibliographic Level Mode of Issuance: Monograph 311 $a0-8165-2909-4 320 $aIncludes bibliographical references and index. 327 $aThe cultural landscape of the highland Maya of Guatemala -- Modern metate production -- Modern patterns of acquisition, use, discard, and reuse -- Archaeological implications. 606 $aMayas$xImplements$zGuatemala$zSan Luis Jilotepeque 606 $aMayas$xImplements$zGuatemala$zIxtahuaca?n 606 $aMayas$xIndustries$zGuatemala$zSan Luis Jilotepeque 606 $aMayas$xIndustries$zGuatemala$zIxtahuaca?n 606 $aMetates$zGuatemala$zSan Luis Jilotepeque 606 $aMetates$zGuatemala$zIxtahuaca?n 606 $aMetate industry$zGuatemala$zSan Luis Jilotepeque 606 $aMetate industry$zGuatemala$zIxtahuaca?n 607 $aSan Luis Jilotepeque (Guatemala)$xSocial life and customs 607 $aIxtahuaca?n (Guatemala)$xSocial life and customs 608 $aElectronic books. 615 0$aMayas$xImplements 615 0$aMayas$xImplements 615 0$aMayas$xIndustries 615 0$aMayas$xIndustries 615 0$aMetates 615 0$aMetates 615 0$aMetate industry 615 0$aMetate industry 676 $a664/.024 700 $aSearcy$b Michael T$g(Michael Taylor),$f1976-$01032957 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910456841803321 996 $aThe life-giving stone$92451167 997 $aUNINA LEADER 04039nam 2200661 a 450 001 9910458840003321 005 20200520144314.0 010 $a1-282-60197-0 010 $a9786612601972 010 $a90-474-4029-3 024 7 $a10.1163/ej.9789004158450.i-292 035 $a(CKB)2670000000011555 035 $a(EBL)489418 035 $a(OCoLC)593315379 035 $a(SSID)ssj0000337782 035 $a(PQKBManifestationID)11929332 035 $a(PQKBTitleCode)TC0000337782 035 $a(PQKBWorkID)10293177 035 $a(PQKB)11489765 035 $a(MiAaPQ)EBC489418 035 $a(OCoLC)80461491 $z(OCoLC)123375640 035 $a(nllekb)BRILL9789047440291 035 $a(PPN)174400772 035 $a(Au-PeEL)EBL489418 035 $a(CaPaEBR)ebr10372683 035 $a(CaONFJC)MIL260197 035 $a(EXLCZ)992670000000011555 100 $a20070123d2007 uy 0 101 0 $aeng 135 $aurun| uuuua 181 $ctxt 182 $cc 183 $acr 200 10$aFool me twice$b[electronic resource] $eintelligence failure and mass casualty terrorism /$fThomas E. Copeland 210 $aLeiden ;$aBoston $cMartinus Nijhoff$dc2007 215 $a1 online resource (318 p.) 225 0 $aNijhoff eBook titles 2007 300 $aDescription based upon print version of record. 311 $a90-04-15845-6 320 $aIncludes bibliographical references (p. 275-288) and index. 327 $tPreliminary Material /$rT.E. Copeland -- $tChapter 1. Introduction /$rT.E. Copeland -- $tChapter 2. February 26, 1993: The World Trade Center /$rT.E. Copeland -- $tChapter 3. April; 19, 1995: Oklahoma City /$rT.E. Copeland -- $tChapter 4. June 25, 1996: Khobar Towers, Saudi Arabia /$rT.E. Copeland -- $tChapter 5. August 7, 1998: U.S. Embassies In Kenya And Tanzania /$rT.E. Copeland -- $tChapter 6. September 11,2001: The Twin Towers /$rT.E. Copeland -- $tChapter 7. Surprise, Again And Again /$rT.E. Copeland -- $tAppendix . Government-Imposed Restrictions On Fbi Domestic Terrorism Investigations /$rT.E. Copeland -- $tBibliography /$rT.E. Copeland -- $tIndex /$rT.E. Copeland. 330 $aThis study evaluates whether surprise and intelligence failure leading to mass casualty terrorism are inevitable. It explores the extent to which four factors ? failures of public policy leadership, analytical challenges, organizational obstacles, and the inherent problems of warning information ? contribute to intelligence failure. The study applies existing theories of surprise and intelligence failure to case studies of five mass casualty terrorism incidents: World Trade Center 1993; Oklahoma City 1995; Khobar Towers 1996; East African Embassies 1998; and September 11, 2001. A structured, focused comparison of the cases is made using a set of thirteen probing questions based on the factors above. The study concludes that while all four factors were influential, failures of public policy leadership contributed directly to surprise. Psychological bias and poor threat assessments prohibited policy makers from anticipating or preventing attacks. Policy makers mistakenly continued to use a law enforcement approach to handling terrorism, and failed to provide adequate funding, guidance, and oversight of the intelligence community. The study has implications for intelligence reform, information sharing, congressional oversight, and society?s expectations about the degree to which the intelligence community can predict or prevent surprise attacks. 606 $aIntelligence service$zUnited States$xEvaluation 606 $aTerrorism$xPrevention 606 $aBombings 608 $aElectronic books. 615 0$aIntelligence service$xEvaluation. 615 0$aTerrorism$xPrevention. 615 0$aBombings. 676 $a363.325/163 700 $aCopeland$b Thomas E$0233109 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910458840003321 996 $aFool me twice$92119128 997 $aUNINA LEADER 05285nam 22006494a 450 001 996214598003316 005 20230617004749.0 010 $a1-280-19832-X 010 $a9786610198320 010 $a0-470-79836-X 010 $a0-470-75525-3 010 $a1-4051-4607-9 035 $a(CKB)1000000000342064 035 $a(EBL)233081 035 $a(OCoLC)437147401 035 $a(SSID)ssj0000160075 035 $a(PQKBManifestationID)11183349 035 $a(PQKBTitleCode)TC0000160075 035 $a(PQKBWorkID)10182549 035 $a(PQKB)10709460 035 $a(MiAaPQ)EBC233081 035 $a(Au-PeEL)EBL233081 035 $a(CaPaEBR)ebr10243497 035 $a(CaONFJC)MIL19832 035 $a(EXLCZ)991000000000342064 100 $a20030602d2003 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aFungal infection$b[electronic resource] $ediagnosis and management /$fMalcolm D. Richardson, David W. Warnock 205 $a3rd ed. 210 $aMalden, Mass. $cBlackwell$d2003 215 $a1 online resource (394 p.) 300 $aDescription based upon print version of record. 311 $a1-4051-1578-5 320 $aIncludes bibliographical references and index. 327 $a""Fungal Infection: Diagnosis and Management""; ""Contents""; ""Preface to the third edition""; ""Preface to the first edition""; ""Acknowledgements""; ""1 Introduction""; ""1.1 The nature of fungi""; ""1.2 Classification and nomenclature of fungi and fungal diseases""; ""1.3 Fungi as human pathogens""; ""1.3.1 The superficial mycoses""; ""1.3.2 The subcutaneous mycoses""; ""1.3.3 The systemic mycoses""; ""1.4 The changing pattern of fungal infection""; ""1.5 New directions in diagnosis""; ""1.6 New directions in treatment and prevention""; ""2 Laboratory diagnosis of fungal infection"" 327 $a""2.1 Introduction""""2.2 Collection of specimens""; ""2.2.1 Skin, nails and hair""; ""2.2.2 Mucous membranes""; ""2.2.3 Ear""; ""2.2.4 Eye""; ""2.2.5 Blood""; ""2.2.6 Cerebrospinal fluid""; ""2.2.7 Urine""; ""2.2.8 Other fluids""; ""2.2.9 Lower respiratory tract specimens""; ""2.2.10 Pus""; ""2.2.11 Bone marrow""; ""2.2.12 Tissue""; ""2.3 Specimens for serological tests""; ""2.4 Specimens for antifungal drug level determinations""; ""2.5 Transport of specimens""; ""2.6 Interpretation of laboratory test result""; ""2.6.1 Direct microscopic examination"" 327 $a""2.6.2 Histopathological examination""""2.6.3 Culture""; ""2.6.4 Serological tests""; ""2.7 Molecular diagnosis of fungal infection""; ""3 Antifungal drugs""; ""3.1 Introduction""; ""3.2 Amphotericin B""; ""3.2.1 Mechanism of action""; ""3.2.2 Spectrum of action""; ""3.2.3 Acquired resistance""; ""3.2.4 Pharmacokinetics""; ""3.2.5 Pharmaceutics""; ""3.2.6 Therapeutic use""; ""3.2.7 Mode of administration""; ""3.2.8 Adverse reactions,""; ""3.2.9 Drug interactions""; ""3.3 Other polyene compounds for topical administration""; ""3.3.1 Natamycin""; ""3.3.2 Nystatin""; ""3.4 Fluconazole"" 327 $a""3.4.1 Mechanism of action""""3.4.2 Spectrum of action""; ""3.4.3 Acquired resistance""; ""3.4.4 Pharmacokinetics""; ""3.4.5 Pharmaceutics""; ""3.4.6 Therapeutic use""; ""3.4.7 Mode of administration""; ""3.4.8 Adverse reactions""; ""3.4.9 Drug interactions""; ""3.5 Itraconazole""; ""3.5.1 Mechanism of action""; ""3.5.2 Spectrum of action""; ""3.5.3 Acquired resistance""; ""3.5.4 Pharmacokinetics""; ""3.5.5 Pharmaceutics""; ""3.5.6 Therapeutic use""; ""3.5.7 Mode of administration""; ""3.5.8 Adverse reactions""; ""3.5.9 Drug interactions""; ""3.6 Ketoconazole""; ""3.6.1 Mechanism of action"" 327 $a""3.6.2 Spectrum of action""""3.6.3 Acquired resistance""; ""3.6.4 Pharmacokinetics""; ""3.6.5 Pharmaceutics""; ""3.6.6 Therapeutic use""; ""3.6.7 Mode of administration""; ""3.6.8 Adverse reactions""; ""3.6.9 Drug interactions""; ""3.7 Voriconazole""; ""3.7.1 Mechanism of action""; ""3.7.2 Spectrum of action""; ""3.7.3 Acquired resistance""; ""3.7.4 Pharmacokinetics""; ""3.7.5 Pharmaceutics""; ""3.7.6 Therapeutic use""; ""3.7.7 Mode of administration""; ""3.7.8 Adverse reactions""; ""3.7.9 Drug interactions""; ""3.8 Other imidazole compounds for topical administration""; ""3.8.1 Bifonazole"" 327 $a""3.8.2 Butoconazole"" 330 $aConcise, up-to-date guide to the clinical manifestations, laboratory diagnosis and management of superficial, subcutaneous and systemic fungal infections ""I would recommend this book to all microbiologists and clinicians regularly dealing with patients suffering from fungal infections."" Journal of Medical Microbiology WHY BUY THIS BOOK? Thorough update of significant developments in the diagnosis and management of fungal infections Up-to-date drug and dosage recommendations updated in line with current guidelines New feature: epidemiology and prevention section in each chapter plu 606 $aMycoses 615 0$aMycoses. 676 $a616.9/69 700 $aRichardson$b M. D$0860654 701 $aWarnock$b D. W$0864389 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a996214598003316 996 $aFungal infection$91929353 997 $aUNISA